Amgen reviews

Not great stock/equity options Executive and senior management is very slow to change Lots is said about career development, but I haven’t seen career trajectory for many people, as most people leave instead to have upward mobility because of fixed rigidity to “promotion cycles” instead of being flexible with the staff and promotions/merit increases Communication about major changes is often sent out late to staff or not at all Company seems more invested in buying innovation through other companies than creating their own innovative products Company is years behind other comparable biotechs Pay is paltry compared to so many other companies in the areas, especially with Thousand Oaks being so expensive Pay increases are also a joke (typically 2-3%), especially considering inflation is 8-10% around the world. Scientific pipeline groups (R&D, PD) seem to be underinvested compared to marketing, corporate affairs, etc. The constant talk about diversity is a farce, as in many departments, I can count black and Latinx folks on my thumbs. You’d be surprised too, as they use all these diverse people on their job postings, but reality is far from their postings suggest (look up “ 2020 EMPLOYER INFORMATION REPORT EEO-1 Amgen” and the first link from Amgen shows ~500 of nearly 12k employees are black, only ~1100 of them are Hispanic or Latino)

managers like to micro manage your everyday activities. salary is just OK. some are underpaid. raise is not based on your performance but if you are liked by the manager. minor races may be treated different compare to major ones. Although someone may perform worse than you but if the manager likes him, he still get the raise but you are not!